AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Infliximab in Ghana
2 products registered with FDA Ghana — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Remicads 100mg Powder for Concentrate for Solution (Infliximab) | UNKNOWN-46a6dffd | — | active | 1 May 2031 |
| Remicads 100mg Powder for Concentrate for Solution (Infliximab) | UNKNOWN-2b5d27eb | — | active | 1 May 2031 |
Infliximab — FDA Ghana Registration Details
FDA Ghana (Ghana) has 2 registered products containing Infliximab, of which 2 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Infliximab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.